ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

GMDA Gamida Cell Ltd

0,0327
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gamida Cell Ltd GMDA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 0,0327 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,0327 0,0327
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/4/202413:30GLOBEXORTX Welcomes New Member to the Board of Directors
01/4/202414:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
27/3/202411:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
14/2/202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202412:31EDGAR2Form 8-K - Current report
08/1/202413:00EDGAR2Form 8-K - Current report
18/12/202312:28EDGAR2Form 8-K - Current report
15/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202323:24EDGAR2Form S-3/A - Registration statement under Securities Act of..
24/11/202322:15EDGAR2Form 8-K - Current report
20/11/202323:27EDGAR2Form SC 13D/A - General statement of acquisition of..
15/11/202323:24EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202313:00EDGAR2Form 8-K - Current report
14/11/202313:00GLOBEGamida Cell Reports Third Quarter 2023 Financial Results and..
08/11/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:01EDGAR2Form 8-K - Current report
11/10/202313:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/10/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
29/9/202314:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/9/202322:43EDGAR2Form 8-K - Current report
13/9/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202322:08EDGAR2Form PRE 14A - Other preliminary proxy statements
21/8/202323:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202322:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:30EDGAR2Form 8-K - Current report
11/7/202314:00BWData Published in Transplantation and Cellular Therapy..
10/7/202320:00PRNUSSTAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE..
14/6/202322:30BWGamida Cell To Host Investor Day
31/5/202322:30BWGamida Cell to Present Corporate Highlights at the Jefferies..
31/5/202313:00BWData To Be Presented on Gamida Cell Natural Killer (NK) Cell..
22/5/202314:00BWGamida Cell Appoints Terry Coelho as CFO
15/5/202322:05BWGamida Cell Reports First Quarter 2023 Financial Results and..
11/5/202323:20BWGamida Cell Announces the Date of Its First Quarter 2023..

Dernières Valeurs Consultées

Delayed Upgrade Clock